Kazakhstan, Hong Kong ‘can build biotech unicorns by linking talent and capital’

AI Summary

Kazakhstan and Hong Kong are exploring partnerships to create biotech unicorns by connecting Kazakhstan’s strong tech talent pool with Hong Kong’s financial resources. The growing biotech sector in Kazakhstan includes companies in AI and digital health, aiming to leverage innovation for business growth.

Kazakhstan and Hong Kong could partner to build biotech unicorns – private start-ups valued at US$1 billion or more – by linking the Central Asian country’s strong tech workforce with the city’s global financial network, a top academic has said. Huck-Hui Ng, dean of the school of medicine at Kazakhstan’s Nazarbayev University, said the nascent biotech sector in the country has already produced several start-ups in areas including artificial intelligence (AI) and digital health, and could build a...